Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Mar 21 04:00PM ET
1.35
Dollar change
-0.05
Percentage change
-3.57
%
Index- P/E- EPS (ttm)-0.03 Insider Own13.25% Shs Outstand34.06M Perf Week-20.59%
Market Cap45.98M Forward P/E- EPS next Y-0.18 Insider Trans-0.84% Shs Float28.04M Perf Month-25.00%
Income-0.77M PEG- EPS next Q-0.04 Inst Own25.63% Short Float1.64% Perf Quarter-39.19%
Sales101.49M P/S0.45 EPS this Y-400.00% Inst Trans-14.97% Short Ratio1.70 Perf Half Y-66.42%
Book/sh0.96 P/B1.41 EPS next Y-23.33% ROA-1.38% Short Interest0.46M Perf Year-4.26%
Cash/sh0.63 P/C2.13 EPS next 5Y-18.56% ROE-2.86% 52W Range1.33 - 5.15 Perf YTD-33.82%
Dividend Est.- P/FCF14.41 EPS past 5Y66.71% ROI-1.76% 52W High-73.79% Beta1.54
Dividend TTM- Quick Ratio2.22 Sales past 5Y10.96% Gross Margin17.23% 52W Low1.50% ATR (14)0.14
Dividend Ex-Date- Current Ratio2.63 EPS Y/Y TTM93.09% Oper. Margin0.60% RSI (14)30.84 Volatility9.50% 7.37%
Employees244 Debt/Eq0.42 Sales Y/Y TTM21.38% Profit Margin-0.76% Recom1.00 Target Price5.67
Option/ShortYes / Yes LT Debt/Eq0.34 EPS Q/Q56.44% Payout- Rel Volume2.42 Prev Close1.40
Sales Surprise4.95% EPS Surprise-706.06% Sales Q/Q11.64% EarningsMar 20 BMO Avg Volume271.17K Price1.35
SMA20-16.95% SMA50-27.15% SMA200-45.29% Trades Volume656,043 Change-3.57%
Date Action Analyst Rating Change Price Target Change
Nov-14-24Initiated Rodman & Renshaw Buy $5
Jun-24-19Initiated Piper Jaffray Overweight $10
May-13-19Initiated H.C. Wainwright Buy $11
Nov-08-16Downgrade BofA/Merrill Neutral → Underperform
Mar-01-16Downgrade Stifel Buy → Hold
Aug-13-15Initiated Morgan Stanley Underweight $7
Jan-27-15Reiterated Oppenheimer Outperform $24 → $26
Jan-07-15Initiated Oppenheimer Outperform $24
Aug-14-14Initiated FBR Capital Underperform $6
Dec-19-13Initiated Chardan Capital Markets Buy $22
Mar-21-25 07:08AM
03:02AM
Mar-20-25 11:44PM
09:37AM
09:36AM
07:10AM Loading…
07:10AM
06:18AM
06:00AM
Mar-19-25 06:00PM
Mar-11-25 06:00AM
Feb-27-25 06:00AM
Feb-20-25 06:00AM
Feb-04-25 06:00AM
Dec-17-24 07:51AM
06:00AM
03:48PM Loading…
Dec-13-24 03:48PM
12:11PM
Dec-12-24 06:00AM
Dec-05-24 06:00AM
Nov-19-24 06:00AM
Nov-13-24 02:06AM
Nov-12-24 10:01PM
07:10AM
06:12AM
06:00AM
Nov-11-24 07:21AM
Nov-08-24 07:06AM
06:00AM
Oct-17-24 12:00PM
Oct-14-24 06:00AM
05:33PM Loading…
Oct-09-24 05:33PM
Sep-20-24 09:15AM
Sep-18-24 06:00AM
Sep-09-24 12:00PM
08:50AM
06:00AM
Sep-04-24 09:15AM
Sep-03-24 06:00AM
Aug-19-24 09:15AM
Aug-15-24 08:50AM
Aug-08-24 07:15AM
06:13AM
06:00AM
Aug-07-24 06:00AM
Jul-15-24 06:45AM
Jul-11-24 06:00AM
May-30-24 06:00AM
May-15-24 08:19AM
03:01AM
12:37AM
May-14-24 10:54AM
07:15AM
06:11AM
06:00AM
Apr-17-24 06:00AM
Apr-16-24 06:00AM
Apr-04-24 06:00AM
Mar-26-24 06:15PM
Mar-25-24 06:00AM
Mar-22-24 09:52AM
Mar-21-24 09:39PM
10:53AM
07:10AM
06:18AM
06:00AM
Mar-11-24 06:15PM
Mar-05-24 06:00PM
Feb-27-24 06:00PM
Feb-20-24 06:00PM
Feb-14-24 06:00PM
Feb-08-24 06:00AM
Jan-08-24 07:30AM
Nov-15-23 01:29PM
Nov-14-23 10:36PM
07:15AM
06:06AM
06:00AM
Nov-07-23 06:00PM
Oct-26-23 06:00PM
Oct-20-23 06:15PM
Oct-18-23 06:00AM
Oct-17-23 06:00AM
Oct-16-23 06:00AM
Oct-13-23 06:15PM
Oct-03-23 06:15PM
06:00AM
Sep-28-23 06:00AM
Sep-27-23 06:15PM
Sep-21-23 06:15PM
06:30AM
Sep-18-23 11:37AM
Sep-07-23 06:00AM
Aug-15-23 12:29PM
Aug-14-23 10:53PM
06:08AM
06:00AM
Aug-11-23 10:28AM
Aug-10-23 10:00AM
Aug-09-23 06:00AM
Aug-01-23 06:25PM
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini on October 25, 1996 and is headquartered in Wixom, MI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chole TimothySVP, Chief Commercial OfficerJan 02 '25Sale2.051,0012,05254,170Jan 06 04:44 PM
Strobeck MarkPresident and CEOJan 02 '25Sale2.062,1634,445145,038Jan 06 04:43 PM
Strobeck MarkOfficerJan 02 '25Proposed Sale2.062,1634,445Jan 02 03:18 PM
Chole TimothyOfficerJan 02 '25Proposed Sale2.011,0012,015Jan 02 12:40 PM
RAVICH MARK HDirectorNov 15 '24Sale2.3219,99146,3790Nov 19 04:21 PM
RAVICH MARK HDirectorNov 15 '24Sale2.4010,00024,000121,429Nov 19 04:21 PM
Chole TimothySVP, Chief Commercial OfficerOct 01 '24Sale3.691,0013,68955,171Oct 02 09:55 PM
Strobeck MarkPresident and CEOOct 01 '24Sale3.692,1637,971147,201Oct 02 09:54 PM
Strobeck MarkOfficerOct 01 '24Proposed Sale3.652,1637,900Oct 01 02:05 PM
Chole TimothyOfficerOct 01 '24Proposed Sale3.601,0013,600Oct 01 01:36 PM